|
C1ORF69 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.62447832963153E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.62436730732907E-12 |
| Normal-vs-Stage2 |
3.21420667859229E-12 |
| Normal-vs-Stage3 |
1.62447832963153E-12 |
| Normal-vs-Stage4 |
<1E-12 |
| Stage1-vs-Stage2 |
3.763600E-03 |
| Stage1-vs-Stage3 |
1.770050E-01 |
| Stage1-vs-Stage4 |
2.792600E-04 |
| Stage2-vs-Stage3 |
7.585300E-04 |
| Stage2-vs-Stage4 |
4.02139999999829E-06 |
| Stage3-vs-Stage4 |
4.688000E-02 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.62436730732907E-12 |
| Normal-vs-AfricanAmerican |
1.67765801251107E-12 |
| Normal-vs-Asian |
<1E-12 |
| Caucasian-vs-AfricanAmerican |
6.144400E-01 |
| Caucasian-vs-Asian |
4.137000E-01 |
| AfricanAmerican-vs-Asian |
9.193200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
<1E-12 |
| Normal-vs-Female |
<1E-12 |
| Male-vs-Female |
4.289800E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
<1E-12 |
| Normal-vs-Age(41-60Yrs) |
<1E-12 |
| Normal-vs-Age(61-80Yrs) |
<1E-12 |
| Normal-vs-Age(81-100Yrs) |
9.59109999976171E-07 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.741400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.865200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.598800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.283200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.345600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.218200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.81879999949786E-07 |
| Classical-VS-Follicular |
5.976400E-02 |
| Classical-VS-Other |
1.166990E-01 |
| Classical-VS-Normal |
<1E-12 |
| Tall-VS-Follicular |
4.39739999968936E-08 |
| Tall-VS-Other |
8.295400E-01 |
| Tall-VS-Normal |
<1E-12 |
| Follicular-VS-Other |
5.924300E-02 |
| Follicular-VS-Normal |
1.62436730732907E-12 |
| Other-VS-Normal |
7.15589999478183E-08 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
<1E-12 |
| Normal-vs-N1 |
<1E-12 |
| N0-vs-N1 |
2.787100E-04 |
|
|
